Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3b, Multicenter, Randomized, Controlled, Double-Blind Clinical Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines in Adults Aged 18 to 59 Years.

NCT06973772 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT06973772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06973772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3b, Multicenter, Randomized, Controlled, Double-Blind Clinical Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines in Adults Aged 18 to 59 Years.
Lead sponsor
Butantan Institute
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 31, 2027
Completion date
October 31, 2027
Enrollment
900 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chikungunya, dengue